Sinopharm
1099.HK
#1990
Rank
A$12.23 B
Marketcap
$3.92
Share price
0.76%
Change (1 day)
-2.06%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2023 (TTM): A$3.61 Billion

According to Sinopharm's latest financial reports the company's current earnings are A$84.39 Billion. a decrease over its 2022 earnings that were of A$5.26 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2023

Annual earnings

Year Earnings Change
2023 A$5.22 B-0.73%
2022 A$5.26 B-1.72%
2021A$5.35 B11.7%
2020A$4.79 B18.44%
2019A$4.04 B10.85%
2018A$3.65 B3.05%
2017A$3.54 B36.48%
2016A$2.59 B7.11%
2015A$2.42 B12.38%
2014A$2.15 B25.05%
2013A$1.72 B22.54%
2012A$1.40 B35.43%
2011A$1.03 B52.24%
2010A$0.68 B30.99%
2009A$0.52 B60.59%
2008A$0.32 B48.29%
2007A$0.21 B123.29%
2006A$98.04 M